Cerner Builds Reference Lab Network

September 29, 2011

Cerner Builds Reference Lab Network

A single connection for instant access to all reference labs

KANSAS CITY, Mo. — Sept. 29, 2011 Cerner Corporation (Nasdaq: CERN) has created a groundbreaking solution to correct a fragmented system within the reference lab connectivity world. Using a cloud-based approach, the Cerner® Reference Lab Network (RLN), part of the Cerner® Network, requires one standard connection to communicate with all reference labs on the network, limiting the need for paper-based processes and increasing the efficiencies within the laboratory.

Historically, hospitals and health care providers have communicated with contracted performing labs through a point-to-point interface, accompanied with a connection fee per interface. This costly model puts limitations on a provider’s options, perpetuating the use of a paper-based system to correct the imbalance. By utilizing the RLN, all lab data are securely stored electronically within the lab system, laying the infrastructure to communicate with a host of reference labs across the country.

Additional benefits include:

  • A single connection that sends orders to multiple lab facilities
  • Instant connectivity to all labs on the network, regardless of the lab’s volume level
  • Increased efficiencies through electronic communication
  • Increased ability to capture discreet reference data

The unique RLN model, developed by Cerner just over a year ago, has already anchored a strong community of industry partners. Some initial partners include:

  • Integrated Regional Laboratories (IRL) – IRL is an advanced referral laboratory providing physicians and hospitals real time results. IRL offers an expansive diagnostic testing menu including Infectious Disease, Molecular, Histology and Pathology services. Today, IRL performs over 8 million clinical tests annually and operates 24/7.
  • Viracor-IBT Laboratories – Viracor-IBT Laboratories is accelerating medicine through innovative molecular and immunodiagnostics, scientific expertise and exceptional services. More than 4,000 health care providers, commercial laboratories and biopharmaceutical companies rely on Viracor-IBT Laboratories to deliver solutions to challenging clinical diagnostic problems in infectious disease, allergy, hypersensitivity and immune disorders. Leveraging expertise and clinical reference laboratory experience, Viracor-IBT Laboratories also works with vaccine, pharmaceutical, biotech and medical device developers to provide infectious disease testing, immune monitoring and bioanalytical services.
  • Alegent Health Laboratory Services – Alegent Health is comprised of eight hospitals, 44 primary care clinics and 100 service sites throughout eastern Nebraska and western Iowa. Alegent Health unites hospital-based laboratories with an off-site reference laboratory. This allows for a unique blend of inpatient, outpatient and physician office records that provide continuity of care for our patients. Alegent Health Laboratory offers a broad range of testing services and integration with local, regional and national electronic health records.
  • Prometheus Laboratories – Prometheus Laboratories focuses on the detection, diagnosis and treatment of disorders within the fields of gastroenterology and oncology.
  • Blood Center of Wisconsin – Blood Center of Wisconsin is a multi-faceted, world-renowned organization focused on blood collection, disease testing, treatment and research. Diagnostic Laboratories develop and perform highly specialized tests on patient samples from throughout the United States and the world. The highly specialized testing and expert medical consultation provided by Diagnostic Laboratories benefits patients in need of bone marrow or organ transplants, patients with bleeding and clotting disorders and patients with immunologic, neoplastic or genetic diseases.

To view the full list of partner laboratories visit

The partner laboratories have made a significant contribution to the network and set the groundwork for establishing a new connection model for the reference laboratory market. “With the change to a transactional model where the reference lab pays a small fee per order, it opens the door for an electronic connection for all reference labs, independent of test volumes,” said John David Nolen, M.D., Ph.D., M.S.P.H., Cerner director of laboratory strategy. “The cost of the interface now aligns with the work being done over that interface.”

About Cerner

Cerner is transforming health care by eliminating error, variance and waste for healthcare providers and consumers around the world. Cerner® solutions optimize processes for healthcare organizations ranging in size from single-doctor practices, to health systems, to entire countries, for the pharmaceutical and medical device industries, employer health and wellness services industry and for the healthcare commerce system. These solutions are licensed by approximately 9,000 facilities around the world, including more than 2,600 hospitals; 3,500 physician practices covering more than 30,000 physicians; 500 ambulatory facilities, such as laboratories, ambulatory centers, cardiac facilities, radiology clinics and surgery centers; 800 home health facilities; and 1,600 retail pharmacies. The trademarks, service marks and logos (collectively, the “Marks”) set forth herein are owned by Cerner Corporation and/or its subsidiaries in the United States and certain other countries throughout the world. Nasdaq: CERN. For more information about Cerner, please visit, Twitter, Facebook and YouTube.

Cerner Media Contact: Matt Dunn, (816) 446-1292,

Cerner Investors Contact: Allan Kells, (816) 201-2445,